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We analyzed the FANTOM2 clone set of 60,770 RIKEN full-length mouse cDNA sequences and 44,122 public
mRNA sequences. We developed a new computational procedure to identify and classify the forms of splice
variation evident in this data set and organized the results into a publicly accessible database that can be used
for future expression array construction, structural genomics, and analyses of the mechanism and regulation of
alternative splicing. Statistical analysis shows that at least 41% and possibly as much as 60% of multiexon genes
in mouse have multiple splice forms. Of the transcription units with multiple splice forms, 49% contain
transcripts in which the apparent use of an alternative transcription start (stop) is accompanied by alternative
splicing of the initial (terminal) exon. This implies that alternative transcription may frequently induce
alternative splicing. The fact that 73% of all exons with splice variation fall within the annotated coding region
indicates that most splice variation is likely to affect the protein form. Finally, we compared the set of
constitutive (present in all transcripts) exons with the set of cryptic (present only in some transcripts) exons and
found statistically significant differences in their length distributions, the nucleotide distributions around their
splice junctions, and the frequencies of occurrence of several short sequence motifs.
[Supplemental material is available online at www.genome.org.]
Numerous databases of alternative splice forms have been
generated in recent years (Stamm et al. 1994; Burke et al.
1998; Gelfand et al. 1999; Mangan and Frazer 1999; Mironov
et al. 1999; Brett et al. 2000; Croft et al. 2000; Ji et al. 2001;
Kan et al. 2001; Kent and Zahler 2001; Modrek et al. 2001),
and analysis of their contents indicates a number of general
facts about splicing and its mechanisms. First, the frequency
of multiexon genes with multiple gene structures is high in
mammals (Mironov et al. 1999; Lander et al. 2001; Modrek et
al. 2001; Brett et al. 2002; Zavolan et al. 2002). The highest
estimates are 59% (Lander et al. 2001) for human genes and
33% (Brett et al. 2002) for mouse genes, raising the question
of whether the complexity of gene structure is lower in mouse
than in human. Second, most of the splice variation affects
the coding region. This has been inferred using (1) a relatively
small subset of EST clusters carefully curated (Modrek et al.
2001) and (2) automated analysis of cDNA data (Zavolan et al.
2002).
Exon inclusion into mature mRNA is a complex choice
whose outcome is influenced by a variety of factors. Many
exons are “cryptic” in the sense that they are included in
some but not all transcripts, through mechanisms that are
presently not completely understood. Cryptic exons have
been reported to be shorter, on average, than constitutive
exons (Berget 1995) and to be flanked by weaker splice sites
(Stamm et al. 2000). Although exon splice enhancers can
compensate for weaker splice sites (Berget 1995; Fairbrother et
al. 2002), it is unclear at present whether constitutive and
cryptic exons differ in the content of splice enhancers. Fi-
nally, studies using full-length cDNA sequences indicate that
alternative transcription initiation (Suzuki et al. 2001; FAN-
TOM2 Consortium and the RIKEN GSC Genome Exploration
Group 2002; Zavolan et al. 2002) and alternative choice of
polyadenylation sites (Zavolan et al. 2002) further enhance
proteome diversity.
To make effective use of the large repertoire of tran-
scripts, a cell must be able to tightly regulate their expression.
With the completion of the mouse genome sequence (ftp://
wolfram.wi.mit.edu/pub/mousecontigs/MGSCV3) and a very
large collection of mouse full-length cDNAs (FANTOM2 Con-
sortium and the RIKEN GSC Genome Exploration Group
2002), the body of data available for testing hypotheses about
the regulation of alternative splicing has improved, both
quantitatively and qualitatively. Full-length cDNA sequences
are obtained using mRNA trapping techniques designed to
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capture polyadenylated transcripts carrying the cap structure
(Carninci et al. 1996). Multiple full-length cDNA sequences
derived from the same “transcription unit” (a segment of the
genome from which transcripts are generated; FANTOM2
Consortium and the RIKEN GSC Genome Exploration Group
2002) reveal the full spectrum of exon combinations that are,
indeed, generated by the spliceosome, and they enable analy-
ses of the cis-acting elements that contribute to differential
exon usage. Sequences of introns, exons, and upstream and
downstream regions are available for a large set of transcripts
unambiguously mapped to the genome.
Here we report the results of our analysis of splice varia-
tion in the FANTOM2 clone set of 60,770 RIKEN full-length
mouse cDNA sequences and 44,122 public mRNA sequences.
RESULTS
Frequency of Alternative Splicing
in the Mouse Transcriptome
Of 60,770 RIKEN full-length mouse cDNA sequences and
44,122 public mRNA sequences, 101,356 aligned to 36,617
genomic loci. A locus was defined based on the genomic map
of the transcripts: Two transcripts were clustered together if
their genomic maps overlapped by at least one nucleotide in
at least one exon. We defined the genomic locus of a tran-
script cluster as the shortest genomic interval that contains
the genomic maps of all of the transcripts in the cluster. We
found that 77,640 of the cDNA sequences mapped to the ge-
nome at >95% identity over their entire length, with every
exon being mapped at 95% identity or with at most five
errors. Of these transcripts, 23,150 were either unspliced or
came from single-exon genes. Of the remaining 54,490 multi-
exon transcripts, 7293 did not cluster with any other tran-
scripts (we called these transcripts singletons), whereas 47,197
formed 11,677multitranscript clusters, which we analyzed for
splice variation. We constructed the union of the genomic
mappings of all transcripts in a cluster and denoted the con-
tiguous genomic regions in this union of mappings as “ge-
nomic exons.” A genomic exon represented in some, but not
all, transcripts in a cluster was denoted “cryptic.” A genomic
exon with different 5 and/or 3 boundaries in different tran-
scripts, was denoted an exon with “alternative 3- and/or 5-
splice sites.” We chose not to report cases in which the varia-
tion could be explained by an intron inclusion, because we
cannot readily distinguish computationally between intron
inclusion and incomplete splicing. Genomic exons that were
represented with the same splice junctions in all transcripts
that were long enough to have contained them were denoted
“constitutive.” A cluster with at least one variant genomic
exon was denoted “variant.” Of the 11,677 multitranscript
clusters, 41% (4750) were variant (Table 1).
This value is larger than our previous estimate on a
smaller data set of full-length mouse cDNAs (30%; Zavolan et
al. 2002), and larger than indicated by ESTs (33%; Brett et al.
2002). The real value is expected to be even higher, as many
of the variants generated in vivo are rare, specific to tissues
and developmental stages. Furthermore, the RIKEN cDNA
cloning strategy, involving sequential subtraction and nor-
malization of libraries, is actually designed to avoid redun-
dant sequencing of cDNAs derived from the same transcrip-
tion unit (see Discussion). The extent to which this strategy
failed is in part attributable to the frequency with which the
outputs of individual transcription units vary at the 5 and 3
ends, and are therefore clustered independently in Phase 1
sequencing (FANTOM2 Consortium and the RIKEN GSC Ge-
nome Exploration Group 2002).
From our (Zavolan et al. 2002) as well as other studies
(Kan et al. 2002), it is clear that the estimated frequency of
genes with alternative splice forms increases with the depth of
sampling, that is, with the average number of transcripts se-
quenced for a gene. Some of the clusters for which we have
not yet found any splice variants will eventually acquire splice
forms as more transcripts are sequenced. To account for the
limited sampling of transcripts, we developed a Bayesian
model (see Methods) that allows us to estimate the probability
that a gene has multiple splice forms, even though only iden-
tically spliced transcripts were observed in our data. The mod-
el’s estimate depends crucially on the prior distribution that
we assume for the number of splice forms per gene, and the
prior for the relative frequencies of occurrence of these splice
forms in the cDNA pool. As explained in Methods, we chose
these priors to bias the estimate toward a high number of
genes with multiple splice forms. As a result, one can consider
the estimate from this model as an upper bound on the inci-
dence of genes with multiple splice forms. The value that we
obtained is 60%. Therefore, we estimate at present that the
frequency of multiexon mouse genes that have multiple
splice forms is at least 41% and may be as high as 60%.
Characterization of Splice Variants
Of all 55,534 genomic exons in variant clusters, 9427 (17%)
show splice variation. Of the 9427 variant genomic exons,
6635 were cryptic exons, of which 2927 occurred as initial or
terminal in a transcript and 3708 occurred in internal posi-
tions. The remaining 2792 variant genomic exons were con-
stitutive, with alternative 5- and/or 3-splice sites. We devel-
oped a Bayesian model (see Meth-
ods) to investigate if alternative
splice site usage correlates with
exon skipping and found a poste-
rior probability Pc = 0.71 for this
correlation to exist. Thus, there is
little evidence in our data for a cor-
relation between exon skipping and
alternative choice of splice signals.
We sought to independently
validate the exon variants using
mouse EST sequences from the
dbEST database. EST mappings were
filtered with the same stringency as
the cDNA mappings, and were
Table 1. Mouse Transcriptome Summary. Flow of the Data Through Our
Analysis Procedure
Data set description
Riken sequences only Riken and GenBank sequences
Sequences Clusters Sequences Clusters
Genome-mapped 60,301 33,936 101,356 36,617
Quasi-complete mappings 51,741 30,447 77,640 33,042
Spliced 31,593 16,541 54,490 18,970
Singletons 9,260 9,260 7,293 7,293
Multitranscript 22,333 7,281 47,197 11,677
Alternative splicing 10,601 3,121 22,150 4,750
Without splice variation 11,732 4,160 25,047 6,927
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searched for the presence of the variant exon forms. An exon
variation was considered confirmed when all the exon forms
used to infer the variation were present in the EST data. That
is, a confirmed cryptic exon is an exon that is present in some
EST but skipped in others. A cryptic exon with alternative
5-splice sites is confirmed when both forms of splice site us-
age, as well as the skipped form occur in the EST data. Table 2
summarizes the results. It is not surprising that multiple varia-
tions are confirmed at lower rates than single variations.
Given that most ESTs are the result of 3- or 5-end sequenc-
ing, it is also to be expected that internal cryptic exons have
lower confirmation rates than initial or terminal cryptic ex-
ons. Exons with multiple variations have, however, lower
confirmation rates than we would predict if each variation
requires independent confirmation. This indicates that cer-
tain of the variant exon forms are less common than others.
For instance, such forms may be expressed in only a few cell
types, or are generated through infrequent errors of the spli-
ceosome (see below). Kan et al. (2002) made similar observa-
tions based on analysis of individual splicing events.
Functional Splice Variation Versus Noise
in the Splicing Process
We observed that alternative 5/3-splice sites are frequently
only a few nucleotides apart, indicating that some of the
variation may be caused by random use of 5- and 3-splice
sites within a short region around the exon boundary. To
document this effect, we isolated exons with alternative 5-
and 3-splice sites that matched the genome perfectly for at
least 10 nt from the splice junction, and were preceded/
followed by invariant exons with perfect alignment to the
genome for at least 10 nt from the splice junction. This selec-
tion ensures that the variation in the placement of the splice
junction is not caused by sequencing, assembly, or mapping
errors. We then computed the distribution of distances be-
tween these alternative splice sites (Fig. 1). In 83 (18%) of the
452 cases of alternative 5-splice sites and 237 (40%) of the
587 cases of alternative 3-splice sites, the distance between
alternative sites was <10 nt.
Whereas alternative 3-splice sites seem to be selected for
preserving the reading frame, alternative 5 sites are not. In
310 (52.8%, p-value < 2.2 1016) of the 587 cases of exons
with alternative 3-splice sites, the distance between these
sites was a multiple of 3, compared with 159 (35.2%, p-
value = 0.4247) of the 452 alternative 5-splice sites. The
asymmetry is, however, entirely due to the frequent use (161
of 587 cases) of alternative 3-splice sites that are only 3 nt
apart. In summary, our data indicate that the spliceosome
may frequently “slip” around the splice junction, and that, at
the 3 site, slips that preserve the reading frame are more
common than others.
Impact of Splice Variation on the Proteome
Splice variation significantly enhances the proteome diver-
sity. We estimated that 6225 (74%) of 8456 variant exons
(cryptic and/or with alternative 5/3-splice sites) overlap with
the coding region of the transcript. This fraction is similar to
the value reported by Modrek et al. (2001) for human tran-
scripts. Localization of splice variation was determined rela-
tive to the coding region of the representative sequences
(FANTOM2 Consortium and the RIKEN GSC Genome Explo-
ration Group 2002) of each cluster (see Methods) and is sum-
marized in Table 3. Of all variant clusters, 4242 have been
annotated as protein-encoding. Of these, 933 (22%) have
cryptic initial and/or terminal exons that lie entirely within
the coding region. These transcripts, if translated, would miss
either initial and/or terminal parts of the protein. In contrast
to transcripts that are merely truncated, the presence of an
alternative splice in these initial exons indicates that they are
not simply the result of nucleotide loss during the experimen-
tal procedure. Such variants may have important functional
implications, as has been recently shown for the STAT pro-
teins (Henriksen et al. 2002).
Representation of Gene Ontology Categories
in Variant and Invariant Clusters
To explore the functional repertoire of splice variants, we ex-
tracted from the variant and invariant clusters 4236 and 6234
representative transcripts (FANTOM2 Consortium and the
RIKEN GSC Genome Exploration Group 2002), respectively.
Representative transcripts from 3018 (71.2%) variant and
4758 (76.3%) invariant clusters matched to 2522 gene ontol-
ogy (GO) term assignments (Table 4). Of those, 407 (16.1%)
GO terms were associated only with representatives of variant
clusters (Supplementary Table 1; available online at www.
genome.org), 829 (32.8%) GO terms only with representatives
of invariant clusters (Supplementary Table 2), and 1286 (51%)
GO terms occurred among representatives of both types of
clusters (Supplementary Table 3). The lists of 20 most repre-
sented GO terms in variant and invariant clusters share the
terms DNA binding, transcription regulation, signal transduc-
tion, signal transducer, and kinase. In contrast to Modrek and
Lee (2002), who reported that proteins involved in signal
transduction or transcription are highly represented among
splice variants, we found that these categories occur at high
Table 2. Variant Exon Statistics
Alternative SSa
Constitutive exons Cryptic internal exons Cryptic initial/terminal exons
Total EST hit Confirmed Total EST hit Confirmed Total EST hit Confirmed
None 46,107 24,265 (52.6%) 22,180 (91.4%) 3523 1417 (40.2%) 118 (8.3%) 2779 586 (21.1%) 151 (25.8%)
5 1,237 668 (54%) 151 (22.6%) 70 42 (60%) 3 (7.1%) 90 51 (56.7%) 7 (13.7%)
3 1,522 928 (61%) 225 (24.2%) 106 59 (55.7%) 3 (5.1%) 56 27 (48.2%) 4 (14.8%)
5 and 3 33 19 (56.7%) 2 (10.5%) 9 7 (77.8%) 0 (0%) 2 2 (100%) 0 (0%)
dbEST sequences were searched for the presence of the variant exon forms that were identified from cDNA sequences. An exon identified from
cDNA sequences was considered to have an EST hit when at least one EST from dbEST contained some form of that exon. If all the variant forms
were present in the EST data, the exon was considered “confirmed.”




frequency in both variant and invariant clusters. For example,
signal transduction occurs with the same frequency (1:10) in
variant and invariant clusters. However, when comparing GO
terms that were unique to representatives of variant and in-
variant clusters, we found that GO terms related to enzymes
and enzymatic functions occurred more than twice as fre-
quently in invariant (364, 14.4%) as in variant clusters (158,
6.3%). The results imply that there may be only a limited
potential for diversification of enzymatic function through
splice variation.
Comparative Analysis of Cryptic
and Constitutive Exons
The mechanism of exon selection has been extensively stud-
ied (Robberson et al. 1990; Talerico and Berget 1990; Hoffman
and Grabowski 1992; Zahler et al. 1993; Staknis and Reed
1994; Berget 1995; Wang et al. 1995; Caceres and Krainer
1997; McCullough and Berget 1997; Liu et al. 1998; Eldridge
et al. 1999; Tacke and Manley 1999; Blencowe et al. 2000).
However, the details of this process are not understood to the
extent that a computational tool can predict alternative splice
forms for a given locus. There are some indications that cryp-
tic exons are shorter and/or have weaker splice sites (Domin-
ski and Kole 1992; Berget 1995; Stamm et al. 2000). We sought
to test these hypotheses in the context of our data set. For this
purpose, we extracted a set of constitutive exons that were
found to be included as internal exons with invariant splice
sites in transcripts from at least four different libraries. This
constitutes our reference set of constitutive exons
(n = 15,298). We also extracted the set of cryptic internal ex-
ons that were present in only two forms in our data set: in-
cluded with invariant splice sites, and skipped (n = 3468).
A Kolmogorov-Smirnov test indicates that the length dis-
tribution of constitutive exons differs significantly from that
of cryptic exons (Fig. 2, p-value = 2.075 1012). Contrary to
our expectation that cryptic exons would
be shorter than constitutive exons (Berget
1995), we observed an enrichment of
cryptic exons at both small and large exon
lengths. Cryptic exons have a larger mean
and also a larger variance (142.4 192.7
vs. 129.2 92.2). The difference between
the length distribution of cryptic exons
that we find and that reported based on
EST analysis may be explained by the fact
that very long internal exons are under-
represented in EST data. This would lead
to the disappearance of the right-hand tail
in the length distribution for cryptic ex-
ons in Figure 2.
Figure 3 shows the distribution of nucleotides found
around the splice sites in constitutive and cryptic exons (see
Methods). The slightly larger size of the letters in the upper
panels indicates that the splice junctions flanking constitu-
tive exons show more conservation than those flaking cryptic
exons. Statistically significant differences (see Methods) are
apparent at positions +1, +4, and +5 in the 5-splice site and
positions5 and6 in the 3-splice site (Fig. 4). These results
are consistent with previous observations that cryptic exons
have “weaker” splice sites (Stamm et al. 2000). Exons flanked
by weak splice signals and otherwise skipped will be included
in the mRNA if the exons are modified to contain exonic
splice enhancers (ESEs; Liu et al. 1998; Schaal and Maniatis
1999; Tacke and Manley 1999; Fairbrother et al. 2002). These
are short sequence motifs, occurring naturally in the vicinity
of the splice signals (Berget 1995; Fairbrother et al. 2002),
known to promote the inclusion of exons in the mature
mRNA.
We sought to identify sequence motifs that are over- or
underrepresented in cryptic exons relative to constitutive ex-
ons, and are therefore candidate regulatory elements respon-
sible for the inclusion of the cryptic exon in the mature
mRNA. We extracted candidate motifs as described in Meth-
ods. In short, we select all motifs that occur significantly more
frequently in constitutive than cryptic exons (or vice versa),
and whose frequency is significantly different from that ex-
pected from themononucleotide frequencies in at least one of
the two sets of exons. We classified these motifs based on (1)
the neighboring splice site (5 or 3); (2) over- or underrepre-
sentation in constitutive versus cryptic; (3) over- or underrep-
resentation of the motif when compared with the frequency
expected from the mononucleotide frequencies in the exon
set.
The most striking patterns that emerged are the follow-
ing. Some of the previously reported splice enhancers (Fair-
brother et al. 2002) are overrepresented in constitutive exons
Table 3. Localization of Splice Variations: Statistics
Splice site usage
Constitutive exons Cryptic internal exons Cryptic initial/terminal exons
5-UTR CDS 3-UTR ?a 5-UTR CDS 3-UTR ?a 5-UTR CDS 3-UTR ?a
Invariant 4046 36,540 2531 2990 453 2632 114 324 802 1487 140 350
Alternative 5 285 768 55 129 9 51 5 5 40 42 2 6
Alternative 3 211 1,104 74 133 19 73 5 9 0 44 9 3
Alternative 5 and 3 2 17 4 10 1 7 0 1 1 0 0 1
aExons from clusters without an annotated protein-coding region.
Figure 1 Distribution of distances between alternative splice sites: (A) 5-splice sites; (B)
3-splice sites. Note that we only show the distribution up to a distance of 100 nt.
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compared with cryptic exons. Of these, TGAAG- and AAGAA-
containing motifs are overrepresented in both constitutive
and cryptic exons relative to their mononucleotide frequen-
cies. In contrast, TGGA-containing motifs are enriched in
constitutive exons but depleted in cryptic exons relative to
the mononucleotide frequencies. Virtually all motifs that are
depleted in both constitutive and cryptic exons relative to the
mononucleotide frequencies, but are overrepresented in con-
stitutive exons, are CG-dinucleotide-containing motifs. This
enrichment is not due to an overall higher C + G content of
constitutive exons (data not shown).
In contrast, cryptic exons are enriched in pyrimidine-
rich motifs, reminiscent of the SRp20-specific motifs de-
scribed by Schaal and Maniatis (1999), or perhaps of motifs to
which the polypyrimidine-tract-binding protein binds (Fair-
brother and Chasin 2000). Additionally, a number of our mo-
tifs resemble binding sites of hRNP proteins A1 (Burd and
Dreyfuss 1994; Chabot et al. 1997), F and H (Min et al. 1995),
and of p54nrb (Basu et al. 1997). These binding sites are G-rich,
frequently containing an AGGG core, or containing alternat-
ing A and G nucleotides. These results indicate that cryptic
exons not only lack splice enhancers, but also contain signals
that inhibit splicing. The complete set of significant motifs
that we extracted is given in Supplementary Figure 1.
Examples
The entire data set of splice variants can be viewed at http://
genomes.rockefeller.edu/MouSDB. In addition to information
stored locally in our database, we have provided links to ex-
ternal resources such as the FACTS database of functional as-
sociations (http://facts.gsc.riken.go.jp; Nagashima et al. 2003)
and the SMART (http://smart.embl-
heidelberg.de) tool for analysis of protein
domains. These will facilitate exploration
of the functional impact of the splice vari-
ants in our data set.
Here we present one example to illus-
trate the breadth of strategies by which
transcript and protein diversity appear to
be achieved in mouse. In separate analy-
ses, we have noted that alternative splic-
ing is relatively common among the
members of the very large zinc finger fam-
ily of transcription factors, commonly
leading to inclusion or exclusion of indi-
vidual zinc fingers or other functional do-
mains (Ravasi et al. 2003). It is arguable
that if splice variation plays a major role
in the complexity of mammalian develop-
ment, then a relative overrepresentation
of splice variation among regulatory pro-
teins, especially those at the apex of regu-
latory hierarchies, is to be expected. Indeed, we observe that a
relatively large number of examples in our splice variant da-
tabase are transcriptional regulators.
As an example, Figure 5 shows different splice forms of
the polypyrimidine-tract-binding protein (PTB), also known
as hnRNP1, that are observed in our data set. This is an RNA-
binding protein that controls 3-end processing, internal ini-
tiation of translation, and RNA localization, in addition to
splice acceptor recognition. As the figure indicates, this gene,
involved in the control of alternative splicing, is itself exten-
sively alternatively spliced. Human PTB is known to be ex-
pressed in at least three isoforms that differ by the insertion of
19 and 26 amino acids, respectively, between the second and
the third RNA-recognition-motif domains (Romanelli et al.
2000). The latter variant is present in our data set. The differ-
ent isoforms contribute differently to alternative splicing
(Wollerton et al. 2001). Figure 5 shows a large number of
transcripts encoding the mouse polypyrimidine-tract-binding
protein, and a number of new splice forms present in the
FANTOM2 data set. As is the case with many other examples
that we inspected, here splice variation gives rise to transcripts
encoding truncated proteins. This is caused by exon skipping
in transcript AK088126 (riE430004K05) and an alternative
choice of splice sites in transcript AK036745 (ri9830169E20).
The potential intron inclusion in transcript AK037607
(riA130029H05) would also produce a truncated protein by
introducing an in-frame stop codon. Alternative choices of
3-splice site in transcript AK036745 (ri9830169E20) do not
change the reading frame; it only truncates the first RNA-
recognition motif. It will be particularly interesting to see
whether any of these isoforms are expressed in a tissue-
Table 4. Counts of GO Terms Associated with Variant, Nonvariant, and Both Types of Clusters
GO category Variant Variant only Nonvariant Nonvariant only Both
Molecular function 916 (54.1%) 226 (55.5%) 1198 (56.6%) 508 (61.3%) 690 (53.7%)
Cell component 176 (10.4%) 34 (8.6%) 215 (10.2%) 73 (8.8%) 142 (11.0%)
Biological process 601 (35.5%) 147 (36.1%) 702 (33.2%) 248 (29.9%) 454 (35.3%)
Total 1693 (100%) 407 (100.0%) 2115 (100%) 829 (100%) 1286 (100%)
We additionally distinguished GO terms that were associated exclusively with variant or with nonvariant clusters.
Figure 2 Estimated frequency of lengths of constitutive (black) and cryptic (red) exons. For
each value of the length L we determined the frequency in our data set of exons with length




specific manner and contributes to tissue-specific alternative
splicing of other genes.
MouSDB: The Database of Splice Variants Identified
in the Mouse Transcriptome
All multitranscript clusters that we identified in this data set
have been deposited in a Postgres database that can be que-
ried via a Web interface at http://genomes.rockefeller.edu/
MouSDB.We expanded our data set to include not only cDNA
sequences, but also EST sequences that we mapped to the
mouse genome with the same stringency as the full-length
cDNAs. These include 1,440,717 ESTs from the dbEST section
of GenBank, 547,149 RIKEN 5-end, and 1,442,236 RIKEN 3-
end sequences. In addition to browsing precomputed multi-
transcript clusters, a user may perform splice analysis and an-
notation of a set of genes of interest.
DISCUSSION
Our study provides the first database and analysis of alterna-
tive splice forms identified in a large set of full-length cDNAs.
The data set used in this analysis is unique
in the following ways. With ESTs one gen-
erally has to infer the full transcript by
combining sequence from several ESTs,
and there is no guarantee that the inferred
transcript occurs in vivo. In contrast, full-
length cDNAs directly reveal the spectrum
of splice forms that are realized in vivo.
Additionally, the full-length cDNAs and
5- and 3-end EST sequences generated by
the FANTOM project (FANTOM2 Consor-
tium and the RIKEN GSC Genome Explo-
ration Group 2002) allow us to identify
transcription start and termination in the
genome, which is important for the iden-
tification of alternative promoters and
polyadenylation signals. Alternative transcription is of inter-
est not only for the purpose of understanding gene expres-
sion, but also because it can induce variation in the use of
splice sites.
One complication for the analysis of splice variation in
this data set is that the sequences have been generated during
the course of a project aimed at maximizing the nonredun-
dant coverage of the mouse transcriptome. For this reason,
the data set does not cover transcripts in proportion to their
representation in the body (Konno et al. 2001). As we men-
tioned above, sequencing of transcripts with 3 and 5 ends
identical to already sequenced transcripts is suppressed. Note,
however, that this bias cannot be very large because the ma-
jority of multiple-transcript clusters shows no splice variation,
that is, there are still more copies of identical transcripts in
the data than alternative transcripts of the same gene. How-
ever, we must take into account the possibility that internal
splice variation is somewhat underrepresented in our data set,
and we designed our statistical tests such that such a bias
would not affect the general conclusions. The only numbers
that are potentially affected are the relative frequencies of
initial/terminal exons among cryptic exons (which we poten-
tially overestimate) and the frequency with which splice
variation affects the coding region (which we potentially un-
derestimate).
We developed a novel computational tool to automate
the analysis of splice variation in cDNA and EST sequences. It
maps the sequences to the genome, clusters sequences map-
ping to overlapping regions in the genome, produces multiple
alignments of the sequences within a cluster, and annotates
them in terms of splice variation. Our methods are highly
conservative: To reduce the frequency of false positives, we
only use sequences that map to the genome at very high per-
centage identity and coverage. This methodology can be ap-
plied to any set of EST or cDNA sequences for which the
corresponding genome has been sequenced.
We organized the data into a publicly accessible resource
that can be used to study specific genes of interest, for expres-
sion array construction, and for further analyses of the
mechanism and regulation of alternative splicing. To increase
our coverage of splice forms in the mouse transcriptome, we
also incorporated 5- and 3-end RIKEN EST sequences and
EST sequences from dbEST. Both data sets (cDNA sequences
only and cDNA + EST sequences) are accessible at http://
genomes.rockefeller.edu/MouSDB. The database provides in-
formation about transcripts derived from individual tran-
scription units and can be searched in various ways, including
by gene name. The information includes multiple sequence
Figure 4 Position-specific probability that the nucleotides at (A) 5- and (B) 3-splice signals
of cryptic exons were generated from different versus the same underlying distribution as those
of the constitutive exons.
Figure 3 Nucleotide distribution in the (A,C) 5- and (B,D) 3-splice
signals flanking constitutive (upper panels) and cryptic (lower panels)
exons. The relative sizes of the letters indicate the relative frequencies
of the nucleotides at that distance from the splice junctions. The
absolute sizes of the letters correspond to the information score of the
nucleotide distribution at that position.
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alignments, functional annotation, the tissues from which
the transcripts have been derived, and annotation of the
splice variation observed in the transcripts. One may, for in-
stance, use the database to discover novel splice forms for
genes of interest, and to explore the tissue-specificity of ex-
pression patterns of various splice forms. For each cDNA se-
quence, our interface provides annotation of the coding re-
gion and links to external databases such as the FACTS func-
tional annotation database and the SMART tool for protein
domain identification, allowing one to evaluate the effects of
the splice variation at the protein level. The database can also
be used to identify alternative promoters and polyadenylation
signals, which, as our analysis indicates, may be an important
source of proteome diversity. Using the genomic mapping
coordinates that we provide, one can extract the sequence of
putative alternative promoters from the publicly available
draft of the mouse genome to search for upstream regulatory
elements. Recognizing that sequence data continue to accu-
mulate, we allow users to perform these analyses on new sets
of sequences by submitting them to the Web interface of our
programs.
We found that 41% of the loci for which multiple spliced
transcripts were present in the data set had multiple splice
forms. We took advantage of the functional annotation of
these sequences to confirm that most of the splice variation
occurs inside the protein-coding region. Interestingly, in al-
most half of all transcription units that show splice variation,
we found cases in which an apparent alternative transcription
start (stop) site is associated with an alternative splice in the
initial (terminal) exon. The use of alternative transcription in
these cases indicates that the alternative splice forms are dif-
ferentially expressed and are, therefore, functional. We also
found numerous examples of exons whose alternative splice
sites are only a few nucleotides apart, indicating that the
spliceosome can slide around the splice junction.
Finally, given the high frequency of alternative splicing
in mammalian genomes, the regulation of alternative splicing
has now become a prominent question. How does the cell
ensure that the appropriate splice forms are expressed in the
right place and at the right time? Our
analysis confirms that the splice junctions
around cryptic exons deviate from those
flanking constitutive exons, and we iden-
tified the precise positions at which sig-
nificant deviations occur. We also found
compositional differences between cryptic
and constitutive exons, one notable differ-
ence being the enrichment of pyrimidine-
rich motifs in cryptic exons. Other motifs,
previously reported to act as splice en-
hancers (Fairbrother et al. 2002), are
found at significantly higher frequencies
in constitutive exons. In contrast to pre-
vious reports that cryptic exons tend to be
shorter than constitutive exons, we find
that both short and large exon lengths are
overrepresented in the cryptic set. This
could indicate that different mechanisms
are involved in the recognition of short
versus long exons. Further analyses of the
relative lengths of the cryptic exons and
their flanking introns may reveal that the
inclusion of cryptic exons in the mature
mRNA is sometimes due to exon defini-
tion and other times to intron definition (Berget 1995). One
of the most important applications that we envision for our
database of alternative splice forms is to provide the data on
which such hypotheses can be tested.
METHODS
Data Sets and Mapping
The cDNA collection used in this study comprised the RIKEN
set of 60,770 full-length mouse cDNA sequences and 44,122
public domain mouse mRNA sequences from LocusLink and
from the non-EST divisions of the Mouse Gene Index and
GenBank (FANTOM2 Consortium and the RIKEN GSC Ge-
nome Exploration Group 2002). The procedure for construct-
ing high-content, full-length libraries has been described in
detail in Carninci et al. (1996). This procedure takes advan-
tage of biochemical properties of the cap and poly(A) tail, and
produces libraries in which >94% of the clones are full-length.
We aligned the sequences to the mouse genome assembly
(ftp://wolfram.wi.mit.edu/pub/mousecontigs/MGSCV3) us-
ing Paracel BLAST (pb BLASTALL -p BLASTN -e-5). We then
extracted, for each cDNA sequence, the genomic region to
which the largest number of cDNA nucleotides could be
mapped (Kondo et al. 2001). Finally, we aligned each cDNA to
its genomic region using Sim4 (Florea et al. 1999) with stan-
dard parameter settings.
EST sequences from dbEST (May 2002 release) and from
the RIKEN data set of 5- and 3-end sequences were repeat-
masked using the Paracel filtering package (Paracel Inc.) and
aligned to the mouse genome using Paracel BLAST and BLAT
(Kent 2002). We again selected the best locus for each se-
quence (Kondo et al. 2001) and aligned the ESTs to their re-
gions using Sim4 (Florea et al. 1999).
Transcript Clustering Based on the Genome Mapping
Ideally, if the genome assembly were complete and correct,
each transcript would map to exactly one locus (unless, of
course, the genome contains identical copies of the same
gene). In addition, if the genome can be divided into a num-
ber of genes, these genes should be clearly separated by inter-
genic regions, and transcripts whose genomic maps overlap




should represent copies of the same transcription unit. Our
clustering method directly reflects this view. Two transcripts
were placed in a cluster if they mapped in the same orienta-
tion, and if their genomic maps overlapped by at least one
nucleotide in one exon. Using the annotated representative
transcript set (FANTOM2 Consortium and the RIKEN GSC
Genome Exploration Group 2002), we estimated that only 84
of the 11,677 (<1%) of our clusters contained more than one
representative transcript. Thus, cases of overlapping transcrip-
tion units are sufficiently rare that our simple clustering
method correctly retrieves the transcription units.
Characterization of Splice Variation
For the analysis of splice variation we selected transcripts that
mapped quasicompletely to the genome assembly: Only ini-
tial and terminal nucleotides were allowed to remain un-
mapped, >95% of the cDNA sequence had to be involved in
perfect matches with the genome, and every exon had to be
95% identical (or contain at most five errors) to the genome.
These transcripts were clustered as described above. Single-
exon and unspliced transcripts were discarded as they do not
reveal any information about alternative splicing.
Clusters with multiple spliced transcripts were analyzed
for the presence of cryptic exons and exons with alternative
5/3-splice sites. We compared all exons of all transcripts in a
cluster in a pairwise fashion to identify those that used alter-
native 5- and 3-splice sites (Fig. 6). For each exon of a tran-
script, we tabulated all splice sites from the other transcript
falling inside the exon. If the first of these splice sites was a
3-splice site, both exons were marked as having alternative
3-splice sites. If the last of these splice sites was a 5-splice site,
both exons were marked as having alternative 5-splice sites.
Note that this scheme does not classify intron inclusions as
alternative splicing, because the above condition will not be
satisfied. Our classification scheme did not consider intron
inclusions as alternative splicing, because we could not dis-
tinguish them (computationally) from incomplete mRNA
processing. Additionally, we identified cryptic exons, defined
as exons that are present in some and skipped in other tran-
scripts, in a cluster. We distinguished between cryptic exons
internal to a transcript and initial or terminal cryptic exons.
We believe that initial and terminal cryptic exons often occur
in transcripts with alternative transcription, and we wanted to
recognize these as a separate category for further investiga-
tion.
To avoid biases arising from cDNA library construction
and cDNA amplification, we reported variation at the level of
genomic exons. A genomic exon is defined as the union of all
overlapping exons identified in the cDNAs of a cluster. We
propagated the alternative splice information from transcript
exons to the level of genomic exons as follows. A genomic
exon is considered cryptic or constitutive depending on
whether or not it is skipped in some of the transcripts in the
cluster. In cases in which the cryptic exon occurred in both
internal and initial/terminal positions in the transcripts, we
called the genomic exon cryptic internal. If the genomic exon
contained transcript exons with alternative 3- and/or 5-
splice sites, the genomic exon was considered to have alter-
native 5- and/or 3-splice sites.
Estimation of the Frequency of Alternative Splicing
in the Mouse Transcriptome
We set out to estimate the number of mouse genes that have
alternative splice forms even though no alternative splice
forms were found in our data. To this end, we need to calcu-
late the probability P(n | k) that a gene has n splice forms given
that k identically spliced transcripts have been observed. In a
Bayesian framework, this probability depends on the prior
probability P(n) that a gene has n splice forms and on the prior
probability P(p1, p2, , pn | n) for the relative frequencies with
which these splice forms (1 through n) occur in the cDNA
pool from which our data have been generated.
We assume that the prior P(n) is a so-called scale-prior,
P(n)  (1/n). This prior is uniform in log(n), and it is also the
unique prior that is invariant under scale transformations
n → n and transformations of the form n → n. Note that
this prior puts almost all a priori probability on there being a
large number of splice forms.
For the prior P(p1, p2, , pn | n), we take a uniform distri-
bution. This again puts a relatively high a priori weight on
very skewed frequencies pi, and thus increases the a priori
probability of observing only one splice form even if alterna-
tive splice forms exist. Thus, our calculation can be inter-
preted as providing an upper bound on the number of mouse
genes that have alternative splice forms even though only one
splice form occurred in the data. On the other hand, assuming
that none of these genes has alternative splice forms provides
a lower bound.
Given n and pi, the probability of observing k times the
same splice form is given by ∑ni = 1(pi)k. Thus, the probability
P(k | n) of observing k times the same splice form given that
the gene has, in fact, n splice forms is obtained by integrating






kdp1    dpn
dp1    dpn
=
n!k!
n + k − 1!
,
where the integrals are over the simplex pi  0, ∑ni=1 pi = 1.
The posterior probability that the gene has n distinct
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The probability that there is exactly one splice form given that
k identical transcripts have been sampled is P(n = 1 | k) = 1 (1/
k). Thus, the probability that the gene has multiple splice
forms is P(n > 1 | k) = (1/k). We then sum this probability for
all multiple-transcript clusters that have only identical tran-
scripts. In this way, we obtain an estimate for the number of
genes that have multiple splice forms, even though only iden-
tical transcripts were observed. For the 6927 invariant mul-
tiple-transcripts clusters, this leads to an expected value of
1870 clusters (27%) with multiple splice forms. Together with
the clusters for which we already detected splice variation,
this yields an expected frequency of 57% of spliced genes with
multiple splice forms.
This calculation assumes that each transcript in our data
is a sample of an independent mature mRNA. However, be-
cause we cannot exclude that the same transcript was ampli-
fied multiple times through PCR, only transcripts from differ-
ent libraries are guaranteed to be independent. Assuming that
Figure 6 Annotation of variant exons. The splice sites responsible
for the annotation of the associated exons as variant are indicated by
vertical bars. Exons with invariant splice sites are shown in green,
exons with alternative 5 sites are shown in yellow, and those with
alternative 3 sites in blue. Cryptic exons are indicated by a black box
surrounding the exon. Introns are shown in red.
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only transcripts from different libraries are independent, we
have 5996 multiple-transcript invariant clusters of which an
expected 37% have splice variation according to our model.
Combining this again with the transcripts for which splice
variation was observed, we obtain an overall upper bound of
60% for the frequency of splice variation.
Note that transcripts that differ by an intron inclusion
are also guaranteed to be independent and are counted as
such, and that single-transcript clusters are excluded from all
these calculations because they do not contain any informa-
tion about splice variation. Finally, note that our “upper
bound” is not a formal upper bound; for example, it is in
principle conceivable (although extremely unlikely) that ev-
ery gene has an alternative splice form that occurs at such low
frequencies that it would never be observed in our data set.
Relationship Between Exon Skipping and Alternative
Splice Site Usage
To assess if alternative splice site usage correlates with exons
being cryptic, we used the following Bayesian analysis. We
calculate the posterior probability for a model in which exon
“crypticness” is independent of alternative splice site usage
(model 1), and for a model in which these forms of exon
variation are correlated (model 2).
Let n00, n10, n01, and n11 be the number of constitutive
exons with invariant splice sites, cryptic exons with invariant
splice sites, constitutive exons with alternative splice site us-
age, and cryptic exons with alternative splice site usage. Un-
der model 1, let p be the probability that an exon is cryptic
and q the probability that it has alternative splice sites. The
likelihood of the observed data D given p and q is
L1D|p,q = pn10+n111 − pn00+n01qn01+n111 − qn10+n00.
Integrating over p and q with a uniform prior yields
L1D =
n01 + n11!n00 + n10!n10 + n11!n01 + n00!
n + 1!2
,
where n = n00 + n01 + n10 + n11 is the total number of exons.
Under model 2, let p00, p01, p10, p11 be the probabilities of
exons in the corresponding categories to be generated. The
likelihood of the observed data D is
L2D|p = p00n00p01n01p10n10p11n11.






The posterior probability that the exon variations are corre-





Note that this Bayesian test is almost identical to a Fisher
exact test.
Impact of Alternative Splicing on the Proteome
We associated each splice-variant cluster with a representative
transcript as follows. If a cluster contained sequences from the
representative set of transcripts (FANTOM2 Consortium and
the RIKEN GSC Genome Exploration Group 2002), the long-
est of these sequences was chosen as the representative for the
cluster. If a cluster contained no sequence from the represen-
tative set (1207 clusters), the longest cDNA in the cluster was
chosen as the cluster representative. Using the genome map-
ping of the representative transcript associated with the clus-
ter and the FANTOM-annotated coding region (CDS; Furuno
et al. 2003), we determined the genomic coordinates corre-
sponding to the start and end of the coding region. If these
coordinates were not covered by the sequence alignment, we
chose the shortest genomic interval that bounded the CDS. If
initial and terminal nucleotides were not mapped and such an
interval could not be constructed, we chose the first and last
mapped nucleotide of the transcript as the boundary of the
CDS.
Distinct proteins forms will be generated when cryptic
exons are present within the genomic map of the CDS, and
when alternative 5- and/or 3-splice sites fall within the ge-
nomic map of the CDS. All genomic exons falling into one of
these categories were counted as “CDS exons.” Genomic ex-
ons mapped upstream of the translation start of the represen-
tative transcript were counted as “5-UTR exons,” and exons
mapped downstream of the translation stop were counted as
“3-UTR exons.” Some clusters did not contain any transcripts
with a CDS annotation, and for these, CDS status was deemed
“unknown.”
EST Confirmation of Splice Variants
To independently confirm the splice forms in our variant
clusters, we compared the variant exons against mouse mRNA
sequences in the dbEST division of GenBank. We mapped
dbEST sequences to the mouse genome using a strategy simi-
lar to that for mapping full-length cDNAs: We identified the
locus using Paracel BLAST or BLAT (Kent 2002), and then we
identified intron/exon boundaries using Sim4 (Florea et al.
1999). ESTs that mapped with 95% identity to the genome,
with every exon mapped at 95% identity or 5 gaps or mis-
matches, were searched for the presence of the exon forms
that we observed in the cDNA data. Variant exons were con-
sidered confirmed if each of the variant forms was found in at
least one independent EST. For instance, a cryptic exon was
considered confirmed if we found both an EST in which the
exon was included and an EST in which the exon was skipped.
Table 2 shows the results.
Comparison of Splice Signals Flanking Cryptic
and Constitutive Exons
We extracted a data set of 15,298 internal exons that were
found in at least four different libraries and that had no evi-
dence of splice variation. The number of libraries is somewhat
arbitrary, chosen only to enhance our confidence that these
exons are, indeed, constitutive. These constitute our set of
constitutive exons. The set of 3468 cryptic exons consists of
internal exons that were present in at least one transcript and
were skipped in at least one other transcript, but did not have
any evidence of alternative splice site usage. We extracted 15
intronic nucleotides from the 5- and 15 intronic nucleotides
from the 3-splice junction of these exons, and computed the
frequencies f i with which the nucleotides  ∈  = A, C, G, T
appear at distance i from the splice junction. For each position
i we computed the information score Ii of the distribution f
i







and is a measure of the deviation of the distribution of
nucleotides at position i from a random distribution of
nucleotides. The results are shown in Figure 3. The absolute
size of the letters at each position corresponds to the infor-
mation score Ii, and the relative sizes correspond to the rela-
tive frequencies f i.
We additionally want to identify positions in the splice
signal for which there is a significant difference between the
nucleotide distributions of constitutive and cryptic exons. To




the observed nucleotide frequencies assuming that (1) the two
data sets had different underlying nucleotide frequencies at
that position, and (2) the two data sets were generated using
the same underlying nucleotide frequencies at that position.
Under the first model, there are independent frequencies p i
and q i with which the nucleotides  ∈  = A, C, G, T occur at
distance i from the splice junction in constitutive and cryptic
exons. With n i andm
i
 the number of observed nucleotides 
at position i in the two data sets, the likelihood for the ob-


































ni = ∑ ∈ ni, mi = ∑ ∈ mi, and the integrals are over
the simplex ∑pi = ∑qi = 1.
Similarly, if we assume that the nucleotide counts at po-
sition i in the constitutive and cryptic exons derive from the
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The likelihood ratio L1(D
i)/L2(D
i) for each position relative to
both 3- and 5-splice junctions is plotted in Figure 4.
Comparative Analysis of Motif Composition
in Cryptic and Constitutive Exons
For each motif of eight or fewer nucleotides, we computed the
frequency fco of occurrence in the set of 15,298 constitutive
exons, and their frequency fcr in the set of 3468 cryptic exons.
We focused our analysis on 40 nucleotides around the 5- and
3-splice junctions of these exons. Under the assumption that
the probabilities of occurrence of a motif in different exons
and different positions around a given splice junction within
an exon are independent, the number of occurrences of the
motif is binomially distributed. Approximating the binomial
distribution by a Gaussian, we calculated, for each motif, the
z-statistics to determine if the motif is significantly over- or
underrepresented in one category of exons (cryptic or consti-
tutive). For each length l we select all motifs for which the
p-value corresponding to this z-statistic is <4l.
We further purged this list of motifs by removing those
that are contained within longer motifs that also occur in the
list. Finally, we compare the frequencies of the remaining
motifs with the frequencies that we would expect based on
the nucleotide frequencies in constitutive and cryptic exons.
We again calculate the z-statistics and only retain the motifs
that are significantly over- or underrepresented in at least one
set of exons with respect to a mononucleotide frequency
model.
In short, we collect all motifs that have significantly dif-
ferent frequencies of occurrence in constitutive versus cryptic
exons, and whose frequencies of occurrence are significantly
different from the frequencies expected based on the mono-
nucleotide frequencies in at least one set of exons. The result-
ing 90 motifs are shown in Supplementary Figure 1.
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